ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Claritev Appoints Jason Kap to its Board of Directors

Board gains deep technology and innovation expertise to support Claritev’s tech-driven growth strategy

Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, yesterday announced the appointment of Jason Kap to its Board of Directors, effective immediately following his election at the Company’s Annual Meeting of Shareholders on April 30, 2025. Kap brings more than two decades of leadership experience driving technology, pricing and product transformation strategies across the software and services industries, strengthening Claritev’s focus on building a next-generation, tech-centric platform.

Kap currently serves as the founder and Chief Executive Officer of Blue Rocket Incorporated, a pricing and product transformation company. Previously, he was the Chief Executive Officer of Zipwire, Inc., and spent over 16 years at Microsoft Corporation in a series of leadership roles, culminating as General Manager and Senior Director of Worldwide Licensing and Pricing. Kap also served as a visiting scholar at the Massachusetts Institute of Technology (MIT) from 2013 to 2020 and currently serves on the board of directors of HitchPin, Inc. He previously served on the board for several other private companies, including Tarian Technology Corp.

“Jason’s extensive background in technology, pricing and innovation strategy makes him an ideal addition to our Board as we advance our technology-driven transformation,” said Travis Dalton, Chairman, CEO and President of Claritev. “His expertise in leading product innovation and business transformation at some of the world’s most respected organizations will be a tremendous asset as we continue to deliver solutions that drive greater value for our customers and the healthcare system.”

Kap’s appointment comes as Claritev accelerates its focus on using technology, data and insights to make healthcare more affordable, transparent and fair for all. Building on its leadership in healthcare cost optimization and revenue integrity solutions, Claritev is expanding its capabilities through strategic investments, platform enhancements and partnerships to help deliver greater value for employers, payers and patients across the healthcare ecosystem.

“Claritev’s vision to drive affordability, transparency and quality through technology and innovation is both exciting and essential to the future of healthcare,” said Kap. “I look forward to working with the Board and management team to help Claritev accelerate its growth and deliver even greater impact for its customers and the broader healthcare ecosystem.”

About Claritev

Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency and optimizes networks and benefits design in healthcare. By developing purpose-built solutions that support all key stakeholders — including payors, employers, patients, providers and third parties — Claritev is dedicated to making healthcare more accessible and affordable for all.

Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.